{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T16:21:00Z","timestamp":1767198060805,"version":"build-2238731810"},"reference-count":49,"publisher":"Impact Journals, LLC","issue":"34","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,8,23]]},"DOI":"10.18632\/oncotarget.11095","type":"journal-article","created":{"date-parts":[[2016,8,6]],"date-time":"2016-08-06T19:00:26Z","timestamp":1470510026000},"page":"54240-54252","source":"Crossref","is-referenced-by-count":18,"title":["Interferon gamma peptidomimetic targeted to interstitial myofibroblasts attenuates renal fibrosis after unilateral ureteral obstruction in mice"],"prefix":"10.18632","volume":"7","author":[{"given":"Fariba","family":"Poosti","sequence":"first","affiliation":[{"name":"Department of Pathology and Medical Biology, Division of Pathology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands"},{"name":"Department of Microbiology and Immunology, Laboratory of Molecular Immunology, Rega Institute, KU Leuven, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruchi","family":"Bansal","sequence":"additional","affiliation":[{"name":"Department of Biomaterials Science and Technology, Division of Targeted Therapeutics, MIRA Institute, University of Twente, Enschede, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saleh","family":"Yazdani","sequence":"additional","affiliation":[{"name":"Department of Biomaterials Science and Technology, Division of Targeted Therapeutics, MIRA Institute, University of Twente, Enschede, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jai","family":"Prakash","sequence":"additional","affiliation":[{"name":"Department of Biomaterials Science and Technology, Division of Targeted Therapeutics, MIRA Institute, University of Twente, Enschede, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonie","family":"Beljaars","sequence":"additional","affiliation":[{"name":"Department of Pharmacokinetics, Toxicology and Targeting, University of Groningen, Groningen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob","family":"van den Born","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Nephrology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin H.","family":"de Borst","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Nephrology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harry","family":"van Goor","sequence":"additional","affiliation":[{"name":"Department of Pathology and Medical Biology, Division of Pathology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan-Luuk","family":"Hillebrands","sequence":"additional","affiliation":[{"name":"Department of Pathology and Medical Biology, Division of Pathology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaas","family":"Poelstra","sequence":"additional","affiliation":[{"name":"Department of Pharmacokinetics, Toxicology and Targeting, University of Groningen, Groningen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2016,8,5]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/nrneph.2011.149","article-title":"Cellular and molecular mechanisms of renal fibrosis","volume":"7","author":"Liu","year":"2011","journal-title":"Nat Rev Nephrol"},{"key":"2","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/sj.ki.5002343","article-title":"Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes","volume":"72","author":"Wheeler","year":"2007","journal-title":"Kidney international"},{"key":"3","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1172\/JCI31487","article-title":"Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases","volume":"117","author":"Wynn","year":"2007","journal-title":"The Journal of clinical investigation"},{"key":"4","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/nrneph.2010.120","article-title":"Renal fibrosis: novel insights into mechanisms and therapeutic targets","volume":"6","author":"Floege","year":"2010","journal-title":"Nat Rev Nephrol"},{"key":"5","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1172\/JCI72267","article-title":"Cellular and molecular mechanisms in kidney fibrosis","volume":"124","author":"Duffield","year":"2014","journal-title":"The Journal of clinical investigation"},{"key":"6","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1038\/nm.3218","article-title":"Origin and function of myofibroblasts in kidney fibrosis","volume":"19","author":"Kalluri","year":"2013","journal-title":"Nature medicine"},{"key":"7","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1365-2613.2011.00764.x","article-title":"Fibroblasts and myofibroblasts in renal fibrosis","volume":"92","author":"Steadman","year":"2011","journal-title":"International journal of experimental pathology"},{"key":"8","doi-asserted-by":"crossref","first-page":"20045","DOI":"10.1074\/jbc.R700025200","article-title":"Interferons, Interferon Receptors, Signal Transducer and Transcriptional Activators, and Interferon Regulatory Factors","volume":"282","author":"Samuel","year":"2007","journal-title":"The Journal of biological chemistry"},{"key":"9","doi-asserted-by":"crossref","first-page":"e60900","DOI":"10.1371\/journal.pone.0060900","article-title":"Interferon gamma suppresses collagen-induced arthritis by regulation of Th17 through the induction of indoleamine-2,3-deoxygenase","volume":"8","author":"Cho","year":"2013","journal-title":"PloS one"},{"key":"10","article-title":"Interferon-gamma improves renal interstitial fibrosis and decreases intrarenal vascular resistance of hydronephrosis in an animal model","volume":"77","author":"Fan","year":"2011","journal-title":"Urology"},{"key":"11","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1046\/j.1523-1755.1999.00775.x","article-title":"Interferon-gamma inhibits experimental renal fibrosis","volume":"56","author":"El Nahas","year":"1999","journal-title":"Kidney international"},{"key":"12","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1096\/fj.14-258459","article-title":"Selective delivery of IFN-gamma to renal interstitial myofibroblasts: a novel strategy for the treatment of renal fibrosis","volume":"29","author":"Hillebrands","year":"2015","journal-title":"FASEB journal"},{"key":"13","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jconrel.2004.10.020","article-title":"Sustained interferon-gamma delivery from a photocrosslinked biodegradable elastomer","volume":"102","author":"Amsden","year":"2005","journal-title":"Journal of controlled release"},{"key":"14","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1023\/A:1016413428473","article-title":"Stable formulations of recombinant human growth hormone and interferon-gamma for microencapsulation in biodegradable microspheres","volume":"13","author":"Jones","year":"1996","journal-title":"Pharmaceutical research"},{"key":"15","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S0140-6736(09)60551-1","article-title":"Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial","volume":"374","author":"du Bois","year":"2009","journal-title":"Lancet (London, England)"},{"key":"16","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1681\/ASN.2007050532","article-title":"A new look at platelet-derived growth factor in renal disease","volume":"19","author":"Alpers","year":"2008","journal-title":"Journal of the American Society of Nephrology"},{"key":"17","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1007\/s00467-011-1892-z","article-title":"The PDGF family in renal fibrosis","volume":"27","author":"Floege","year":"2012","journal-title":"Pediatric nephrology (Berlin, Germany)"},{"key":"18","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/S0006-2952(03)00445-3","article-title":"The preferential homing of a platelet derived growth factor receptor-recognizing macromolecule to fibroblast-like cells in fibrotic tissue","volume":"66","author":"Poelstra","year":"2003","journal-title":"Biochemical pharmacology"},{"key":"19","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/hep.24395","article-title":"Novel engineered targeted interferon-gamma blocks hepatic fibrogenesis in mice","volume":"54","author":"Poelstra","year":"2011","journal-title":"Hepatology (Baltimore, Md)"},{"key":"20","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1158\/1535-7163.MCT-11-0758","article-title":"Selective targeting of interferon gamma to stromal fibroblasts and pericytes as a novel therapeutic approach to inhibit angiogenesis and tumor growth","volume":"11","author":"Prakash","year":"2012","journal-title":"Molecular cancer therapeutics"},{"key":"21","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jconrel.2014.01.022","article-title":"Interferon gamma peptidomimetic targeted to hepatic stellate cells ameliorates acute and chronic liver fibrosis","volume":"179","author":"Poelstra","year":"2014","journal-title":"Journal of controlled release"},{"key":"22","doi-asserted-by":"crossref","first-page":"e89878","DOI":"10.1371\/journal.pone.0089878","article-title":"Targeted recombinant fusion proteins of IFNgamma and mimetic IFNgamma with PDGFbetaR bicyclic peptide inhibits liver fibrogenesis","volume":"9","author":"Poelstra","year":"2014","journal-title":"PloS one"},{"key":"23","first-page":"72","article-title":"Targeted Therapies in Liver Fibrosis: Combining the Best Parts of Platelet-Derived Growth Factor BB and Interferon Gamma","volume":"2","author":"Beljaars","year":"2015","journal-title":"Frontiers in medicine"},{"key":"24","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1096\/fj.03-1273rev","article-title":"TGF-beta signaling and the fibrotic response","volume":"18","author":"Abraham","year":"2004","journal-title":"FASEB journal"},{"key":"25","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1017\/erm.2014.18","article-title":"Lymphangiogenesis in renal diseases: passive bystander or active participant?","volume":"16","author":"van den Born","year":"2014","journal-title":"Expert reviews in molecular medicine"},{"key":"26","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/cphy.c120012","article-title":"Renal vascular structure and rarefaction","volume":"3","author":"Chade","year":"2013","journal-title":"Comprehensive Physiology"},{"key":"27","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1681\/ASN.2010080793","article-title":"Mechanisms of tubulointerstitial fibrosis","volume":"21","author":"Neilson","year":"2010","journal-title":"Journal of the American Society of Nephrology"},{"key":"28","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1681\/ASN.2006050420","article-title":"Renal fibroblasts and myofibroblasts in chronic kidney disease","volume":"17","author":"Zeisberg","year":"2006","journal-title":"Journal of the American Society of Nephrology"},{"key":"29","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1093\/ndt\/15.10.1535","article-title":"Effects of pentoxifylline, pentifylline and gamma-interferon on proliferation, differentiation, and matrix synthesis of human renal fibroblasts","volume":"15","author":"Muller","year":"2000","journal-title":"Nephrology, dialysis, transplantation"},{"key":"30","first-page":"438","article-title":"Phase I study of recombinant gamma-interferon (rIFN-gamma)","volume":"7","author":"Neidhart","year":"1988","journal-title":"Journal of Biological Response Modifiers"},{"key":"31","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1056\/NEJM199910213411703","article-title":"A preliminary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis","volume":"341","author":"Block","year":"1999","journal-title":"The New England journal of medicine"},{"key":"32","first-page":"167sr1","article-title":"Therapy for fibrotic diseases: nearing the starting line","volume":"5","author":"Violette","year":"2013","journal-title":"Science translational medicine"},{"key":"33","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1021\/mp200263q","article-title":"Peptide-modified albumin carrier explored as a novel strategy for a cell-specific delivery of interferon gamma to treat liver fibrosis","volume":"8","author":"Poelstra","year":"2011","journal-title":"Molecular pharmaceutics"},{"key":"34","first-page":"183","article-title":"Macrophages in kidney injury, inflammation, and fibrosis","volume":"30","author":"Wang","year":"2015","journal-title":"Physiology (Bethesda, Md)"},{"key":"35","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/ki.2010.182","article-title":"CD4+ T cells: a potential player in renal fibrosis","volume":"78","author":"Nikolic-Paterson","year":"2010","journal-title":"Kidney international"},{"key":"36","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/ki.2010.177","article-title":"Pivotal role of CD4+ T cells in renal fibrosis following ureteric obstruction","volume":"78","author":"Wong","year":"2010","journal-title":"Kidney international"},{"key":"37","doi-asserted-by":"crossref","first-page":"C1","DOI":"10.1152\/ajpcell.1999.277.1.C1","article-title":"Myofibroblasts. I. Paracrine cells important in health and disease","volume":"277","author":"West","year":"1999","journal-title":"The American Journal of Physiology"},{"key":"38","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1046\/j.1365-2249.1996.d01-864.x","article-title":"Expression of leucocyte chemoattractants by interstitial renal fibroblasts: up-regulation by drugs associated with interstitial fibrosis","volume":"106","author":"Egido","year":"1996","journal-title":"Clinical and experimental immunology"},{"key":"39","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1172\/JCI74854","article-title":"The lymphatic vasculature revisited","volume":"124","author":"Kerjaschki","year":"2014","journal-title":"The Journal of clinical investigation"},{"key":"40","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/ki.2008.661","article-title":"Lymphatic vessels develop during tubulointerstitial fibrosis","volume":"75","author":"Matsuo","year":"2009","journal-title":"Kidney international"},{"key":"41","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nrneph.2013.35","article-title":"Angiogenesis and hypoxia in the kidney","volume":"9","author":"Nangaku","year":"2013","journal-title":"Nat Rev Nephrol"},{"key":"42","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1089\/jir.2006.26.568","article-title":"Influence of IFN- alpha and IFN- gamma on lymphangiogenesis","volume":"26","author":"Liu","year":"2006","journal-title":"Journal of interferon & cytokine research"},{"key":"43","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s00467-013-2430-y","article-title":"Peritubular capillary rarefaction: a new therapeutic target in chronic kidney disease","volume":"29","author":"Yamaguchi","year":"2014","journal-title":"Pediatric nephrology (Berlin, Germany)"},{"key":"44","doi-asserted-by":"crossref","first-page":"5632","DOI":"10.1128\/JVI.79.9.5632-5639.2005","article-title":"Peptide mimetics of gamma interferon possess antiviral properties against vaccinia virus and other viruses in the presence of poxvirus B8R protein","volume":"79","author":"Johnson","year":"2005","journal-title":"Journal of virology"},{"key":"45","first-page":"4576","article-title":"IFN mimetic as a therapeutic for lethal vaccinia virus infection: possible effects on innate and adaptive immune responses","volume":"178","author":"Johnson","year":"2007","journal-title":"Journal of immunology (Baltimore, Md: 1950)"},{"key":"46","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1006\/bbrc.1994.2375","article-title":"The C-terminus of IFN gamma is sufficient for intracellular function","volume":"203","author":"Johnson","year":"1994","journal-title":"Biochemical and biophysical research communications"},{"key":"47","doi-asserted-by":"crossref","first-page":"5445","DOI":"10.1021\/bi036213t","article-title":"Signal transduction mechanism of a peptide mimetic of interferon-gamma","volume":"43","author":"Johnson","year":"2004","journal-title":"Biochemistry"},{"key":"48","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1089\/107999001753289569","article-title":"Nuclear translocation of IFN-gamma is an intrinsic requirement for its biologic activity and can be driven by a heterologous nuclear localization sequence","volume":"21","author":"Johnson","year":"2001","journal-title":"Journal of interferon & cytokine research"},{"key":"49","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1074\/jbc.274.1.403","article-title":"The carboxyl terminus of interferon-gamma contains a functional polybasic nuclear localization sequence","volume":"274","author":"Johnson","year":"1999","journal-title":"The Journal of biological chemistry"}],"updated-by":[{"DOI":"10.18632\/oncotarget.28532","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T00:00:00Z","timestamp":1706054400000},"record-id":"51322"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.11095","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T05:09:16Z","timestamp":1656997756000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.11095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,5]]},"references-count":49,"journal-issue":{"issue":"34","published-print":{"date-parts":[[2016,8,23]]}},"alternative-id":["11095","27509062"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.11095","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,5]]}}}